Trailing-twelve-month (TTM) revenue is $222.03 Million with a year-over-year growth of +19.58%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $55,652,490 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $40,746,564 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-16 |
| Q1 FY2026Period ended 2026-03-31 | $59,776,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $65,853,546 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $222,028,600 |
Current P/S: $270,027,090 market capitalization ÷ $222,028,600 TTM revenue = 1.22x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:52:45.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $65.85M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:56:55.799Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Reportable Segment | $148M | $203M |
$222.03M
$222.03 Million
+19.58%
vs. $185.67M a year ago (TTM)
+8.23%
5 Year compound annual growth rate
1 Year
+19.58%
3 Year
+15.00%
5 Year
+8.23%
10 Year
+12.02%
15 Year
+15.80%
20 Year
+15.70%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $199.19M | +$44.05M | +28.39% |
| 2024 | $155.14M | +$10.95M | +7.60% |
| 2023 | $144.19M | +$14.03M | +10.78% |
| 2022 | $130.16M | ($31.07M) | (19.27%) |
| 2021 | $161.23M | +$29.86M | +22.73% |
| 2020 |
TTM Growth
+19.58%
3-Year CAGR
+15.00%
5-Year CAGR
+8.23%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $131.37M |
| ($13.75M) |
| (9.48%) |
| 2019 | $145.12M | +$31.35M | +27.55% |
| 2018 | $113.77M | +$21.00M | +22.64% |
| 2017 | $92.77M | +$15.33M | +19.80% |
| 2016 | $77.44M | +$13.26M | +20.66% |
